REMEDi4ALL

📢 Applications extended for the REMEDi4ALL Repurposing Bootcamp for Patient Representatives! Taking place on 10–11 June 2027 in Barcelona, the Bootcamp is designed for representatives of patient organisations based in the EU and UK who want to play an active role in advancing new uses for existing medicines. Join us to build the knowledge and practical skills to help advance promising drug repurposing opportunities towards patient impact. 👉 Learn more and apply today: https://loom.ly/H2FxxGE

📣 The International Drug Repurposing Conference (#iDR27), by REMEDi4ALL and Beacon for Rare Diseases returns on 15–16 June 2027 in London! Under the theme “Further, Together: From science to patient Impact”, iDR27 will explore how promising discoveries, ideas and collaborations can move towards real-world use and patient access. #iDR27 offers an unparalleled opportunity to learn from real-world examples, explore different routes to impact and connect with the people working to bring repurposed drugs to those who need them. 👉 Discover iDR27 and claim your early-bird discount now: https://lnkd.in/erJyDAAt

That's a wrap on GAM 5! 🎉 This week, the REMEDi4ALL consortium came together in Hamburg for the project's fifth General Assembly Meeting. With the project entering its final year, partners reflected on progress to date, reviewed key activities across the consortium, and explored priorities for maximising impact. Discussions also looked ahead to the future of the REMEDi4ALL project and how its resources and expertise can continue to support the drug repurposing community beyond the project lifetime. 👏 Thank you to Fraunhofer ITMP for hosting us in Hamburg, and to all partners for two days of productive discussions and collaboration. 🔗 Learn more about REMEDi4ALL: https://loom.ly/yq8Ulvg

🎥 The REMEDi4ALL Hackathon 2026 Highlights Video is now live! This year's Hackathon provided a unique opportunity to learn, collaborate and develop practical solutions aimed at improving outcomes for people living with rare diseases. Watch our highlights video to hear directly from participants and learn more about the impact of the Hackathon as a training experience. 📖 Read the full recap here: https://loom.ly/czEAwGk ----------------------------------------------------------- Our speakers: Eva Molero Romen, Sofia Sintoris, Adrià Riu i Blasco (Teamit) Rick Thompson, Megan Burley (Beacon for Rare Diseases), Attila Imre (Syreon Research Institute), Swapnil Potdar, PhD., Kristen Michelle Nader (Institute for Molecular Medicine Finland (FIMM)), Nikola Panajotovikj (Chemotargets), Davide Scarpetta (Istituto Mario Negri for Pharmacological Research), Rawya Al-Rifai (Universitätsmedizin Göttingen) & Gamze Özata (Ludwig-Maximilians-Universität München (Ludwig Maximilian University of Munich)) #EUFunded European Health and Digital Executive Agency (HaDEA)

🚀 Kicking off the fifth REMEDi4ALL General Assembly in Hamburg! Today, consortium partners are reflecting on the project's progress and discussing the next steps for advancing patient-centred drug repurposing in Europe and beyond. Day 1 highlights include: 🔹 Patient experiences and lessons from the demonstrator projects 🔹 Scientific outputs and expert-led tools for drug repurposing research 🔹 Connecting the ecosystem through the REMEDi4ALL Concierge, Funders Network, and communication and dissemination activities 🔹 Breakout sessions focused on sustaining the platform, knowledge and expertise beyond the project 🔗 Stay tuned for more: www.remedi4all.org

What can you expect at the REMEDi4ALL Repurposing Bootcamp for Patient Representatives? 💡 Build practical knowledge through real-world cases, interactive workshops and expert-led discussions. 💊 Learn how patient organisations can identify promising drug repurposing opportunities, shape projects and help address common barriers. 🤝 Connect with patient representatives, researchers and experts working across the drug repurposing field. Taking place on 10–11 June 2027 in Barcelona, the Bootcamp is designed for representatives of patient organisations based in the EU and UK who want to play an active role in advancing new uses for existing medicines. 👉 Learn more and apply before 16 October 2026: https://loom.ly/H2FxxGE Beacon for Rare Diseases, EURORDIS-Rare Diseases Europe

Orfenix, a member of the REMEDi4ALL Funders Network, is hosting a webinar on designing registration-ready clinical studies.   Join the session on 13 October to explore four key building blocks of clinical trial design, from development planning and regulatory submissions to study conduct and post-study obligations.   👇 Learn more and register below!

🔍Did you know that REMEDi4ALL has published more than 30 open-access publications covering everything from cutting-edge drug repurposing tools and policy research to real-world case studies and scientific discoveries? 🔬 Explore the latest research on topics including: ✅ Computational drug repurposing and AI-enabled tools ✅ Policy and regulatory barriers to medicines repurposing ✅ Rare diseases and patient-centred innovation ✅ Drug discovery methodologies and translational research ✅ Lessons learned from real-world repurposing initiatives 📚 Browse the full publications collection: https://loom.ly/TxjYWsc

📢 Build the knowledge and practical skills to help advance promising drug repurposing opportunities towards patient impact! Join the REMEDi4ALL Repurposing Bootcamp for Patient Representatives on 10–11 June 2027 in Barcelona. Through expert-led sessions, real-world case studies and interactive discussions, participants will explore: 🔹 Finding and evaluating repurposing opportunities 🔹 Supporting projects as active patient partners 🔹 Developing strategies from concept to patient access 🔹 Funding for promising projects 🔹 Recognising and overcoming common bottlenecks The Bootcamp is open to patient representatives affiliated with patient organisations in the EU and UK. 🔗 Learn more and apply here before 16 October: https://loom.ly/H2FxxGE

💊 Yesterday at REPO4EU's #RExPO26 in Berlin, Patricia Vandamme of the Anticancer Fund presented the session “REMEDi4ALL – Building a sustainable platform, strengthening the Drug Repurposing ecosystem”. The session explored REMEDi4ALL’s progress in supporting patient-centred drug repurposing projects, strengthening connections across the ecosystem and laying the foundations for continued support beyond the project’s Horizon Europe funding period. 👉 Read the session abstract here: https://loom.ly/yR3jKTw